Fluvoxamine (Luvox) Flashcards
(17 cards)
Brand name
Luvox
Luvox CR
Class, MOA
SSRI - 1A receptors
Binds Sigma 1 receptors too
Onset
2-4 weeks
Used mainly for
- OCD
* Social anxiety disorder
S/Es
Same as Sertraline
Unique-
-sigma 1 antagonism - sedation, fatigue
Dose
OCD - 100 to 300 mg
Depression - 100 to 200 mg
Social anxiety disorder - 100 to 300 mg
- For Luvox -
- Start at 50, can inc by 50 every 4-7 days, max 300
- Dose less than 100 can be given once a day at bedtime
- Dose more than 100 can be given as once at bedtime or 2 doses with larger dose at bedtime
- For Luvox CR - Don’t chew or crush.
- Start at 100, can inc by 50 every week, max 200.
OD
Rarely fatal
Sedation, dizziness, vomiting, diarrhea, irregular heartbeat, seizures, coma, breathing difficulty
Taper
50% for 3 days, another 50% for 3 days, stop
Half life
9 - 28 hours
CYP action
Inhibits CYP450
- 3A4 (inc conc of statins, pimozide, carbamazepine, alprazolam, triazolam)
- 1A2 (inc conc of theophylline and clozapine)
- 2C9/2C19
Any specific DIs with fluvoxamine
- Jitteriness, excess stimulation, rarely seizures with caffeine and theophylline
- Metabolism faster in smokers, so need higher dose
- CYP action
C/I with
- MAOIs
- Thioridazine
- Pimozide
- Tizanidine
- Alosetron
- Ramelteon
Allergy
Special populations
*Lower initial dose in hepatic, renal and elderly.
*Approved for OCD in age 8-17 years - Start at 25 mg/day at bedtime, inc by 25 every 4-7 days, max 200mg.
If above 50 mg, divide into 2 doses with larger dose at bedtime.
Advantages
*Mixed anxiety/depression
Disadvantages
- Pts with irritable bowel or multiple GI complaints
* Can need dose titration and BID dosing
Note
*Preferred inn anxiety+depression pts
Sigma 1 action leads to early effect in anxiety and insomnia, and helps in psychotic depression and delusional depression t/t.
*Lower sexual S/Es
*NOT FDA approved for depression
*For t/t resistant OCD, consider fluvoxamine + clomipramine
How does Fluvoxamine + Clomipramine combo work in treatment resistant OCD?
- Clomipramine is a potent serotonin reuptake blocker.
At steady state, it is metabolized into its active metabolite desmethyl-clomipramine, a potent noradrenergic reuptake blocker. - So, at steady state, plasma drug activity is more noradrenergic than serotoninergic.
- Adding a CYP450 1A2 inhibitor, Fluvoxamine, blocks this conversion and results in higher clomipramine levels than desmethyl-clomipramine levels. This enhances serotoninergic effect of clomipramine.
-Plus added Serotoninergic effect of fluvoxamine itself.
-These 2 factors help in t/t resistant OCD.